Neoadjuvant chemotherapy in locally advanced primary breast cancers - The Nottingham experience

European Journal of Surgical Oncology

Volumn 33, Issue 8, 2007, Pages 972-976

  Mathew, J ^a   Asgeirsson, K S ^a   Agrawal, A ^a   Mukherjee, A ^a   Ellis, I O ^a   Cheung, K L ^a   Chan, S Y ^a   Robertson, J F R ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Anthracycline based chemotherapy; Clinical response; Locally advanced breast cancer; Neoadjuvant chemotherapy; Pathological response; Survival

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN; MITOXANTRONE;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MASTECTOMY; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR VOLUME;

ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; METHOTREXATE; MIDDLE AGED; MITOMYCIN; MITOXANTRONE; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34548602580     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.02.005     Document Type: Article

References (23)

1. Erol K., Baltali E., Altundag K., et al. Neoadjuvantt chemotherapy with cyclophosphamide, mithotrixate and 5-flurouracil in locally advanced breast cancer. Onkologie 28 (2005) 81-85
2. Perez C.A., Fields J.N., Fracasso P.M., et al. Management of locally advanced carcinoma of breast. II. Inflammatory carcinoma. Cancer 74 1 Suppl (1994) 466-476
3. Perez C.A., Graham M.L., Taylor M.E., et al. Management of locally advanced carcinoma of the breast. I. Non-inflammatory. Cancer 74 1 Suppl (1994) 453-465
4. Lebowitz P.F., Eng-Wong J., Swain S.M., et al. A phase 11 trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer. Clin Cancer Res 10 (2004) 6764-6769
5. Charfare H., Limongelli S., and Purushotham A.D. Neoadjuvant chemotherapy in breast cancer. Br J Surg 92 (2005) 14-23
6. Early Breast Cancer Trialists Collaborative Group. Polychemotherapy for early breast cancer: an overview of randomised trials. Lancet 352 (1998) 930-942
7. Bull J.M., Tormey D.C., Li S.H., et al. A randomised comparative trial of adriamycin versus methotrixate in combination drug therapy. Cancer 41 (1978) 1649-1657
8. Falkson G., Tormey D.C., Carey P., Ritte R., and Falkson H.C. Long term survival in patients treated with combination chemotherapy for metastatic breast cancer. Eur J Cancer 27 (1991) 973-977
9. Wolmark N., Wang J., Mamounas E., Bryant J., and Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine year results from National Surgical Adjuvant Breast and Bowel project B-18. J Natl Cancer Inst Monogr 30 (2001) 96-102
10. Buzdar A.U., Singletary S.E., Theriault R.L., et al. Prospective evaluation of Paclitaxel versus combination chemotherapy with flurouracil, Doxorubicin, and cyclophosphamide as neoadjuvant therapy inpatients with operable breast cancer. J Clinl Oncol 17 (1999) 3412-3417
11. Barni S., Piazza E., Frontini L., et al. Single-agent Epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma: 6-year follow-up. Oncology 67 (2004) 40-47
12. Tan S.M., Cheung K.L., Willsher P.C., Blamey R.W., Chan S.Y., and Robertson J.F.R. Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy. EJC 37 (2001) 2331-2338
13. McIntosh S., Ogston K., Payne S., et al. Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. Am J Surg 185 (2003) 525-531
14. Shen J., Valero V., Buchholz T.A., et al. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol 11 (2004) 854-860
15. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Eng J Med 337 14 (1997) 956-962
16. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premanopausal women with breast cancer who receive adjuvant chemotherapy. N Eng J Med 337 14 (1997) 949-955
17. Olson J.E., Neuberg D., Pandya K., et al. The role of radiotherapy in the management of operable locally advanced breast carcinoma. Results of a randomised controlled trial. Eastern Cooperative Oncology Group. Cancer 79 6 (1997) 1138-1149
18. Klefstrom P., Grohn P., Hainonen E., Holsti L., and Holsti P. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage 111 breast cancer. 11. 5-year results and influence of levamisole. Cancer 60 5 (1987) 936-942
19. Truong P.T., Olivotto I.A., Whelan T.J., et al. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 170 8 (2004) 1263-1273
20. Ravdin P.M., Burris III H.A., Cook G., et al. Phase 11 trial of docetaxel in advanced anthracycline-resistant or anthacenedione-resistant breast cancer. J Clin Oncol 13 (1995) 2879-2885
21. Valero V., Holmes F.A., Walters R.S., et al. Phase trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metabolic breast cancer. J Clin Oncol 13 (1995) 2886-2894
22. Heys S.D., Hutcheon A.W., Sarkar T.K., et al. Neoadjuvant docetaxel in breast cancer: 3-year survival results from Aberdeen trial. Clin Breast Cancer 3 Suppl (2002) 69-74
23. Bear H.D., Anderson S., Brown A., et al. The effect on tumour response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from national surgical adjuvant breast and bowel project protocol B-17. J Clin Oncol 22 (2003) 4165-4174